RP-1664
Product Specifications
CAS Number
2980682-00-4
Target
PLK
Related Pathways
Cell Cycle/Checkpoint
Purity
0.9904
Bioactivity
RP-1664 is a selective and orally active PLK4 inhibitor with an IC50 of 3 nM. This compound demonstrates exceptional selectivity over related kinases, disrupts centriole biogenesis in cancer cells leading to PLK4 and p21 protein accumulation, shows enhanced sensitivity in TRIM37-high-expressing cells, and exhibits antitumor activity in breast cancer and neuroblastoma research.
Smiles
O=S(=O)(C1=CC(F)=C(C(F)=C1)N(C=2N=C(NC3=NNC(=C3)C)C(=C(N2)C=4N=CN(C4)C)C5CC5)C)C
Molecular Formula
C23H24F2N8O2S
Molecular Weight
514.55
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15092168 1 Vial
Lentiviral human TMED2 shRNA (UAS) - Lentiviral human TMED2 shRNA (UAS, GFP) (25)
Ask
View Details GTR15239133 1 Vial
Lentiviral mouse Zfp110 shRNA (UAS) - Lentiviral mouse Zfp110 shRNA (UAS, GFP) (100)
Ask
View Details 
MBS6357901-01 0.2 mL
TRAF6, ID (TRAF6, RNF85, TNF receptor-associated factor 6, E3 ubiquitin-protein ligase TRAF6, Interleukin-1 signal transducer, RING finger protein 85) (AP)
Ask
View Details 
MBS6357901-02 5x 0.2 mL
TRAF6, ID (TRAF6, RNF85, TNF receptor-associated factor 6, E3 ubiquitin-protein ligase TRAF6, Interleukin-1 signal transducer, RING finger protein 85) (AP)
Ask
View Details